Key result
The mode of presentation of beta2-glycoprotein I greatly influences its recognition by anti-beta2GPI antibodies, revealing marked inter-individual heterogeneity in 56 sera from APS patients.
Authors
Loading...
Presentation mode and inter-patient heterogeneity may confound anti-β2GPI testing in APS; leaves open assay standardization needs.
Observational (n=56)
Regnault et al. (1998) conducted an observational in Antiphospholipid syndrome (APS) (n=56). Beta2-glycoprotein I presentation was evaluated on Reactivity profiles of anti-beta2GPI antibodies to human and bovine beta2GPI. The mode of presentation of beta2-glycoprotein I greatly influences its recognition by anti-beta2GPI antibodies, revealing marked inter-individual heterogeneity in 56 sera from APS patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: